Dr. Daniela Ciltea, MD

Dr. Ciltea practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.

Dr. Ciltea's NPI, 1518186360, was assigned on April 24, 2007. Dr. Ciltea holds Ohio license 35-088371.

Dr. Ciltea's primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.

Dr. Ciltea's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. Dr. Ciltea is also affiliated with Summa Health System - Akron Campus. The medical group on file is Partners Physician Group. Dmand AI also links Dr. Ciltea to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ciltea practices, 6 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Ciltea's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Ciltea is licensed in Ohio.

CMS data shows 571 Medicare services from Dr. Ciltea across 9 procedure codes in 2024, for 272 Medicare patients. Medicare paid $42,348 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 272 Medicare patients who saw Dr. Ciltea in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ciltea's median patient age at 63, with 60% women.

In 2024, Dr. Ciltea wrote 4,084 Medicare Part D claims for 443 patients. 42% of them were for generic drugs. CMS names the drug for 3,505 of them, across 63 drugs with 11 or more claims each, at $1,844,891 in total drug cost. In 2023, CMS named 3,379 claims across 74 drugs.

Dr. Ciltea accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ciltea as offering telehealth.

Dmand AI links 4 papers to Dr. Ciltea, published from 2015 to 2023. The most frequent topics are Biomechanical Phenomena, Gait and Heel. Dr. Ciltea has published most often in J Biomech. Dr. Ciltea's most frequent co-authors are Michael D. Morocco, MD and Braghadheeswar Thyagarajan, MD.

CMS Open Payments shows 185 general payments to Dr. Ciltea from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Eli Lilly and Company paid the most, $13,771.